Title : Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035).

Pub. Date : 2020 May

PMID : 32083163






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here we report the results of an abbreviated trial of AKT inhibitor MK-2206 in platinum resistant high grade serous ovarian, fallopian tube, and primary peritoneal cancer with PTEN loss. Platinum AKT serine/threonine kinase 1 Homo sapiens